Watch this video to gain expert insights on the current treatment options for patients with ERHER2 MBC who experience disease progression after endocrine therapy with a focus on novel therapies in the postCDK46 inhibitor setting
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/oncology/protacs-in-erher2-mbc/32334-61951
- Start Date: 2024-11-19 06:00:00
- End Date: 2024-11-19 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.25 hours
- Commercial Support: Source: Pfizer (Any division) - Amount: 55000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest